460 related articles for article (PubMed ID: 15656799)
41. Activation of the transcription factor Gli1 and the Sonic hedgehog signalling pathway in skin tumours.
Dahmane N; Lee J; Robins P; Heller P; Ruiz i Altaba A
Nature; 1997 Oct; 389(6653):876-81. PubMed ID: 9349822
[TBL] [Abstract][Full Text] [Related]
42. No evidence for mutations in exons 1, 8 and 18 of the patched gene in sporadic skin lesions of Brazilian patients.
Granja F; Santarosa PL; Leite JL; Ward LS
Braz J Med Biol Res; 2003 Apr; 36(4):459-62. PubMed ID: 12700822
[TBL] [Abstract][Full Text] [Related]
43. PTCH mutations and deletions in patients with typical nevoid basal cell carcinoma syndrome and in patients with a suspected genetic predisposition to basal cell carcinoma: a French study.
Soufir N; Gerard B; Portela M; Brice A; Liboutet M; Saiag P; Descamps V; Kerob D; Wolkenstein P; Gorin I; Lebbe C; Dupin N; Crickx B; Basset-Seguin N; Grandchamp B
Br J Cancer; 2006 Aug; 95(4):548-53. PubMed ID: 16909134
[TBL] [Abstract][Full Text] [Related]
44. [Cutaneous epithelial tumors. Molecular biology and pathogenesis-based therapy].
Reifenberger J; Schön MP
Hautarzt; 2003 Dec; 54(12):1164-70. PubMed ID: 14634745
[TBL] [Abstract][Full Text] [Related]
45. Early-onset of sporadic basal-cell carcinoma: germline mutations in the TP53, PTCH, and XPD genes.
Suárez-Martínez EB; Ruiz A; Matías J; Morales L; Cruz A; Vázquez D; Villa J; Matta JL
P R Health Sci J; 2007 Dec; 26(4):349-54. PubMed ID: 18246963
[TBL] [Abstract][Full Text] [Related]
46. PTCH polymorphism is associated with the rate of increase in basal cell carcinoma numbers during follow-up: preliminary data on the influence of an exon 12-exon 23 haplotype.
Strange RC; El-Genidy N; Ramachandran S; Lovatt TJ; Fryer AA; Smith AG; Lear JT; Ichii-Jones F; Jones PW; Hoban PR
Environ Mol Mutagen; 2004; 44(5):469-76. PubMed ID: 15534865
[TBL] [Abstract][Full Text] [Related]
47. Unbalanced overexpression of the mutant allele in murine Patched mutants.
Calzada-Wack J; Kappler R; Schnitzbauer U; Richter T; Nathrath M; Rosemann M; Wagner SN; Hein R; Hahn H
Carcinogenesis; 2002 May; 23(5):727-33. PubMed ID: 12016144
[TBL] [Abstract][Full Text] [Related]
48. High levels of patched gene mutations in basal-cell carcinomas from patients with xeroderma pigmentosum.
Bodak N; Queille S; Avril MF; Bouadjar B; Drougard C; Sarasin A; Daya-Grosjean L
Proc Natl Acad Sci U S A; 1999 Apr; 96(9):5117-22. PubMed ID: 10220428
[TBL] [Abstract][Full Text] [Related]
49. Molecular biology of basal and squamous cell carcinomas.
Emmert S; Schön MP; Haenssle HA
Adv Exp Med Biol; 2014; 810():234-52. PubMed ID: 25207369
[TBL] [Abstract][Full Text] [Related]
50. Mutational analysis of CDKN2A genes in patients with squamous cell carcinoma of the skin.
Saridaki Z; Liloglou T; Zafiropoulos A; Koumantaki E; Zoras O; Spandidos DA
Br J Dermatol; 2003 Apr; 148(4):638-48. PubMed ID: 12752119
[TBL] [Abstract][Full Text] [Related]
51. Analysis of p53 and BAX mutations, loss of heterozygosity, p53 and BCL2 expression and apoptosis in basal cell carcinoma in Korean patients.
Cho S; Hahm JH; Hong YS
Br J Dermatol; 2001 Apr; 144(4):841-8. PubMed ID: 11298546
[TBL] [Abstract][Full Text] [Related]
52. Patched-one or smoothened gene mutations are infrequent in chondrosarcoma.
Yan T; Angelini M; Alman BA; Andrulis IL; Wunder JS
Clin Orthop Relat Res; 2008 Sep; 466(9):2184-9. PubMed ID: 18543049
[TBL] [Abstract][Full Text] [Related]
53. Molecular basis of basal cell carcinogenesis in the atomic-bomb survivor population: p53 and PTCH gene alterations.
Mizuno T; Tokuoka S; Kishikawa M; Nakashima E; Mabuchi K; Iwamoto KS
Carcinogenesis; 2006 Nov; 27(11):2286-94. PubMed ID: 16777989
[TBL] [Abstract][Full Text] [Related]
54. Differential allele loss on chromosome 9q22.3 in human non-melanoma skin cancer.
Holmberg E; Rozell BL; Toftgård R
Br J Cancer; 1996 Jul; 74(2):246-50. PubMed ID: 8688329
[TBL] [Abstract][Full Text] [Related]
55. PTCH mutations in squamous cell carcinoma of the skin.
Ping XL; Ratner D; Zhang H; Wu XL; Zhang MJ; Chen FF; Silvers DN; Peacocke M; Tsou HC
J Invest Dermatol; 2001 Apr; 116(4):614-6. PubMed ID: 11286632
[TBL] [Abstract][Full Text] [Related]
56. Expression of a sonic hedgehog signal transducer, hedgehog-interacting protein, by human basal cell carcinoma.
Tojo M; Kiyosawa H; Iwatsuki K; Kaneko F
Br J Dermatol; 2002 Jan; 146(1):69-73. PubMed ID: 11841368
[TBL] [Abstract][Full Text] [Related]
57. Interaction of hedgehog and vitamin D signaling pathways in basal cell carcinomas.
Albert B; Hahn H
Adv Exp Med Biol; 2014; 810():329-41. PubMed ID: 25207374
[TBL] [Abstract][Full Text] [Related]
58. Genomic profiling of late-onset basal cell carcinomas from two brothers with nevoid basal cell carcinoma syndrome.
Hasan Ali O; Yurchenko AA; Pavlova O; Sartori A; Bomze D; Higgins R; Ring SS; Hartmann F; Bühler D; Fritzsche FR; Jochum W; Navarini AA; Kim A; French LE; Dermitzakis E; Christiano AM; Hohl D; Bickers DR; Nikolaev SI; Flatz L
J Eur Acad Dermatol Venereol; 2021 Feb; 35(2):396-402. PubMed ID: 32564428
[TBL] [Abstract][Full Text] [Related]
59. p53 mutations in human aggressive and nonaggressive basal and squamous cell carcinomas.
Bolshakov S; Walker CM; Strom SS; Selvan MS; Clayman GL; El-Naggar A; Lippman SM; Kripke ML; Ananthaswamy HN
Clin Cancer Res; 2003 Jan; 9(1):228-34. PubMed ID: 12538474
[TBL] [Abstract][Full Text] [Related]
60. PTCH gene mutations in odontogenic keratocysts.
Barreto DC; Gomez RS; Bale AE; Boson WL; De Marco L
J Dent Res; 2000 Jun; 79(6):1418-22. PubMed ID: 10890722
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
